1Gregory YH, Lip MD, Andrew D, et al. Does hypertension confer a prothrombotic state[J]. Circulation, 2000,101(1):218-220.
2Gregory YH, Andrew D, Blann D, et al. Prothrombotic factors,endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension[J].J Hypertens,1999,17(8):1203-1207.
3Sandet PM, Abildgaard U, Putersen MJ. A sensitive assay of extrinsic coagulation pathway inhibitor in plasma and plasma fraction[J]. Thromb Res,1987,47(2):389-400.
4Bashir A, Lwalead, Paul A. The biology and tumor related properties of monocyte tissue factor[J]. J Pathology, 2001,193(1):3-12.
5Macmahon S, Peto R, Cutler J, et al. Blood pressure,stroke,and coronary heart disease[J]. Lancet,1990,335(3):765-826.
7Dorffel Y, Latsch C, Stuhlmuller B, et al. Preactivated peripheral blood monocytes in patients with essential hypertension[J]. Hypertension,1999, 34(1):113-117.
8Rapaport SI, Rao LVM. Initiation and regulation of tissue factor-dependent blood coagulation[J]. Arterioscler Thromb,1992,12(10):1111-1121.
9Meade TW. The epidemiology of atheroma, thrombosis and ischaemic heart disease[J]. Haemost Thromb,1994,2(3):1199-1227.
10Scarabin PY, Aillaud MF, Amonyel P, et al. Associations of fibrinogen, factor Ⅶ and PAI-1 with baseline findings among 10500 male participants in a prospective study of myocardial infarction-the PRIME Study. Prospective Epidemiological Study of myocardia
4Lip GY, Blann AD. Does hypertension confer a prothrombotic state? Virchow's triad revisited [J].Circulation, 2000, 101 (3): 218-220.
5Shah PK. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis? [J]. Circulation, 2002, 105(3): 270- 271.
6Falciani M, Gori AM, Fedi S, et al. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients[J]. Thromb Haemost, 1998, 79(3):495-499.
7Sakkinen PA, Cushman M, Psaty BM, et al. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort [J].Thromb Haemost, 1998, 80(1): 134-139.
8Rudic RD, Shesely EG, Maeda N, et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling [J]. J Clin Invest, 1998, 101(4) : 731-736.
9Sardo MA,Campo S, Castaldo M, et al. Tissue factor expres sion and activity armonocytes isolated from uncomplicated. Hypertension, 2006,24 : 731-736.
